PTGS2 and prostate cancer: Similarly, 1,25 (OH)2D3 reduces the expression of cyclooxygenase-2 (COX-2) and 5-prostaglandin dehydrogenase (15-PGDH), two critical enzymes involved in the metabolism of prostaglandin, which consequently inhibits proliferation of prostate cancer cells.